Cartesian Therapeutics, Inc. Taxes Payable, Current
Cartesian Therapeutics, Inc. (RNAC) had Taxes Payable, Current of $0 as of 2022-12-31, per its 10-K filed 2023-03-02.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:TaxesPayableCurrent · last filed 2023-03-02
- 2022-12-31: Taxes Payable, Current $0.00.
- 2022-09-30: Taxes Payable, Current $0.00.
- 2022-06-30: Taxes Payable, Current $320.00K.
- 2022-03-31: Taxes Payable, Current $320.00K.
| Period end | Taxes Payable, Current |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-02 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-03 |
| 2022-06-30 | $320.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $320.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $601.00K 10-K · filed 2023-03-02 |
| 2021-09-30 | $15.83M 10-Q · filed 2021-11-09 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |